Treatment outcomes of external-beam radiotherapy for squamous cell carcinoma of the base of the tongue

Verfasser / Beitragende:
[Yoshifumi Kawaguchi, Kinji Nishiyama, Takerou Hirata, Kouji Konishi, Shinji Otozai, Motoyuki Suzuki, Tadashi Yoshii, Takashi Fujii, Teruki Teshima]
Ort, Verlag, Jahr:
2015
Enthalten in:
International Journal of Clinical Oncology, 20/5(2015-10-01), 891-896
Format:
Artikel (online)
ID: 60549164X
LEADER caa a22 4500
001 60549164X
003 CHVBK
005 20210128100511.0
007 cr unu---uuuuu
008 210128e20151001xx s 000 0 eng
024 7 0 |a 10.1007/s10147-015-0805-8  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10147-015-0805-8 
245 0 0 |a Treatment outcomes of external-beam radiotherapy for squamous cell carcinoma of the base of the tongue  |h [Elektronische Daten]  |c [Yoshifumi Kawaguchi, Kinji Nishiyama, Takerou Hirata, Kouji Konishi, Shinji Otozai, Motoyuki Suzuki, Tadashi Yoshii, Takashi Fujii, Teruki Teshima] 
520 3 |a Purpose: To evaluate definitive external-beam radiotherapy (EBRT) for patients with base of the tongue (BOT) cancers. Methods: We reviewed results for 26 patients with BOT cancers who were treated with EBRT. Clinical stages T1, T2, T3, and T4a were observed for 10, 7, 4, and 5 patients, respectively, and stages N0, N1, N2a, N2b, N2c, and N3 were observed for 4, 2, 5, 6, 8, and 1 patients, respectively. More than half of the patients (n=19) were stage IVA. Standard total delivered doses were 70Gy to primary tumors and cervical lymph node (CLN) metastases and 40-46Gy to elective nodal regions. Eleven patients with advanced loco-regional disease received concurrent or neoadjuvant chemotherapy. Four T3 patients and one T2 patient received 2 or 3 cycles of concurrent intra-arterial cisplatin with EBRT (RADPLAT). Results: Three-year overall survival was 69% (95% CI 47-83%), with a median follow-up period of 33months. Three-year local control was 100, 86, 100, and 20% for T1, T2, T3, and T4 patients, respectively. Three-year regional control was 100% for N0, N1, and N2a, 83% for N2b, 75% for N2c, and 0% for N3 patients. Treatment failed for 7 patients. All 5 patients undergoing RADPLAT achieved complete responses and did not develop local recurrence. Conclusions: We achieved favorable outcomes for patients with T1-T3 BOT cancers by use of definitive EBRT with or without chemotherapy. 
540 |a Japan Society of Clinical Oncology, 2015 
690 7 |a Base of tongue cancer  |2 nationallicence 
690 7 |a External-beam radiotherapy  |2 nationallicence 
690 7 |a Intra-arterial chemotherapy  |2 nationallicence 
690 7 |a Organ preservation  |2 nationallicence 
700 1 |a Kawaguchi  |D Yoshifumi  |u Department of Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3, Nakamichi 1-chome, Higashinari-ku, 537-8511, Osaka, Japan  |4 aut 
700 1 |a Nishiyama  |D Kinji  |u Department of Radiology, Yao Municipal Hospital, Osaka, Japan  |4 aut 
700 1 |a Hirata  |D Takerou  |u Department of Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3, Nakamichi 1-chome, Higashinari-ku, 537-8511, Osaka, Japan  |4 aut 
700 1 |a Konishi  |D Kouji  |u Department of Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3, Nakamichi 1-chome, Higashinari-ku, 537-8511, Osaka, Japan  |4 aut 
700 1 |a Otozai  |D Shinji  |u Department of Head and Neck Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan  |4 aut 
700 1 |a Suzuki  |D Motoyuki  |u Department of Head and Neck Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan  |4 aut 
700 1 |a Yoshii  |D Tadashi  |u Department of Head and Neck Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan  |4 aut 
700 1 |a Fujii  |D Takashi  |u Department of Head and Neck Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan  |4 aut 
700 1 |a Teshima  |D Teruki  |u Department of Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3, Nakamichi 1-chome, Higashinari-ku, 537-8511, Osaka, Japan  |4 aut 
773 0 |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/5(2015-10-01), 891-896  |x 1341-9625  |q 20:5<891  |1 2015  |2 20  |o 10147 
856 4 0 |u https://doi.org/10.1007/s10147-015-0805-8  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10147-015-0805-8  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kawaguchi  |D Yoshifumi  |u Department of Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3, Nakamichi 1-chome, Higashinari-ku, 537-8511, Osaka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Nishiyama  |D Kinji  |u Department of Radiology, Yao Municipal Hospital, Osaka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Hirata  |D Takerou  |u Department of Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3, Nakamichi 1-chome, Higashinari-ku, 537-8511, Osaka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Konishi  |D Kouji  |u Department of Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3, Nakamichi 1-chome, Higashinari-ku, 537-8511, Osaka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Otozai  |D Shinji  |u Department of Head and Neck Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Suzuki  |D Motoyuki  |u Department of Head and Neck Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Yoshii  |D Tadashi  |u Department of Head and Neck Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Fujii  |D Takashi  |u Department of Head and Neck Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Teshima  |D Teruki  |u Department of Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3, Nakamichi 1-chome, Higashinari-ku, 537-8511, Osaka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/5(2015-10-01), 891-896  |x 1341-9625  |q 20:5<891  |1 2015  |2 20  |o 10147